TP53 and neoplasm: To differentiate between reactive lesion and true neoplasm, analyses for isocitrate dehydrogenase and p53 mutation combined with clinical and radiological assessment can be helpful (Kurtkaya-Yapıcıer et al., 2002; Capper et al., 2010).